Close Menu

Books in a Library

percutaneous coronary intervention

Use of Cystatin C in the Early Diagnosis of Contrast-induced Nephropathy

DOI: 
10.7727/wimj.2015.074
Synopsis: 
In this study, the Cys C level of the CIN group was significantly increased after 24 h or PCI, while the Scr level had no significant synchronic change, and the Cys C and Scr levels of the non-CIN group had no statistical significance before and after the opacification. The cut-off point value of Cys C was 1.50 mg/L, with the sensitivity and specificity as 85.7% and 82.4% respectively, suggesting that the serum Cys C concentrations had a certain value towards the early diagnosis of CIN, better than Scr, and is worthy of clinical application.

ABSTRACT

Objective: The aim of this study was to explore the application values of Cystatin C (cys-C) in the early diagnosis of contrast-induced nephropathy (CIN).

Accepted: 
23 Mar, 2015
PDF Attachment: 
Journal Sections: 
Journal Authors: 
e-Published: 16 Oct, 2015

Disclaimer

Manuscripts that are Published Ahead of Print have been peer reviewed and accepted for publication by the Editorial Board of the West Indian Medical Journal. They may appear in their original format and may not be copy edited or formatted in the style guide of this Journal. While accepted manuscripts are not yet assigned a volume, issue or page numbers, they can be cited using the DOI and date of e-publication. See our Instructions for Authors on how to properly cite manuscripts at this stage. The contents of the manuscript may change before it is published in its final form. Manuscripts in this section will be removed once they have been issued to a volume and issue, but will still retain the DOI and date of e-publication.

Application of Two-Stage Hybrid Coronary Revascularization in Multivessel Coronary Artery Disease

DOI: 
10.7727/wimj.2015.425
Synopsis: 
Two-stage HCR is a safe, effective and minimally invasive method to treat multivessell CAD

ABSTRACT

Objective: The aim of this study was to explore the efficacy of percutaneous coronary intervention (PCI) with minimally invasive direct coronary artery bypass grafting (MIDCABG) in the treatment for multivessel coronary artery disease (CAD).

Accepted: 
11 Sep, 2015
PDF Attachment: 
Journal Sections: 
e-Published: 18 Sep, 2015

Disclaimer

Manuscripts that are Published Ahead of Print have been peer reviewed and accepted for publication by the Editorial Board of the West Indian Medical Journal. They may appear in their original format and may not be copy edited or formatted in the style guide of this Journal. While accepted manuscripts are not yet assigned a volume, issue or page numbers, they can be cited using the DOI and date of e-publication. See our Instructions for Authors on how to properly cite manuscripts at this stage. The contents of the manuscript may change before it is published in its final form. Manuscripts in this section will be removed once they have been issued to a volume and issue, but will still retain the DOI and date of e-publication.

Subscribe to RSS - percutaneous coronary intervention
Top of Page